Escalating Dose Study in Subjects With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom's Macroglobulinemia

Clinical trial NCT01351935 · COMPLETED

Trial details

NCT number

NCT01351935

Sponsor

Celgene

Status

COMPLETED

Phase

Phase 1

Study type

INTERVENTIONAL

Start date

2011-07-18

Primary completion

2015-06-26

Enrollment

113

View on ClinicalTrials.gov